In Brief: FDA Office of Generic Drugs
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of Generic Drugs: Acting Director Douglas Sporn will become deputy director of the new Office of Pharmaceutical Science under Roger Williams, MD, who will head the office as well as serve as deputy center director for pharmaceutical science. Sporn will oversee the establishment of the Office of New Drug Chemistry. A replacement for Sporn, who leaves OGD in August, has not been announced. FDA is recruiting for a permanent director for OGD both inside and outside the agency....
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning